User menu

Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.

Bibliographic reference Grob, Jean-Jacques ; Mortier, Laurent ; D'Hondt, Lionel ; Grange, Florent ; Baurain, Jean Francois ; et. al. Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.. In: ESMO open, Vol. 2, p. e000203 (2017)
Permanent URL http://hdl.handle.net/2078.1/191310